NeuroOne up on completing study of brain monitoring ablation system

Neuroone Medical Technologies

06/12/2022 16:22

** Shares of medical device maker NeuroOne Medical
Technologies Corp  NMTC.O  rise 9.8% to $1.8
    ** Co reports completion of feasibility study for its
ablation system OneRF in an animal model
    ** OneRF technology utilizes existing diagnostic electrodes
surgically implanted into the brain tissue for lesioning
    ** Lesioning is when small areas of damage (lesions) are
made in the brain 
    ** NMTC says OneRF monitors and adjusts settings based on
temperature throughout the surgical removal of body tissues and
sees the technology to improve the safety of the procedure 
    ** If successful, co plans FDA submission of the device in
Q2 of 2023
    ** Co earlier reported it is advancing a pipeline of
therapeutic electrode technologies for chronic back pain
treatment 
    ** Including session's gain, stock is down 7.7% YTD
 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))